National Medical Insurance Administration: The clinical efficacy and safety of generic drugs selected through centralized procurement are equivalent to those of the original drugs

on the 17th, the national medical insurance administration held a press conference to introduce the real-world research results on the clinical efficacy and safety of generic drugs selected from the second and third batches of nationally organized drug centralized procurement. in june 2021, entrusted by the national medical insurance administration, xuanwu hospital of capital medical…